When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital -...
In an unexpected finding, scientists have linked the activation of a stress gene in immune-system cells to the spread of breast cancer to other parts of the body.
Researchers say the study suggests this gene, called ATF3, may be the crucial link between stress and cancer, including the major...
A drug currently used to treat leukaemia might also help prevent breast cancer from spreading to other parts of the body, suggests an animal study in the open-access journal Breast Cancer Research. The discovery could also pave the way for improved early diagnostics. Peter Storz and colleagues...
In a laboratory, preclinical study recently published by the journal Organic & Biomolecular Chemistry, Virginia Commonwealth University Massey Cancer Center researchers combined structural features from anti-nausea drug thalidomide with common kitchen spice turmeric to create hybrid molecules...
The Medical Imaging & Technology Alliance (MITA) has said that a new study published in the journal Nature Medicine on the use of magnetic resonance (MR) imaging to evaluate brain tumors underscores the value of advanced medical imaging in helping physicians evaluate the effectiveness of...
to-BBB, the brain drug delivery company, is pleased to announce the successful completion of its 2B3-101 Phase I part of its clinical trial in brain cancer patients, safely reaching clinically effective dosages. to-BBB is now ready to proceed to the Phase IIa part of this trial, treating...
...it not ring a bell? Or is my calender calculation wrong. It is supposed to be a great event when all these signs are in one house - that is if you remember what event is supposed to happen. Do you remember? if so, can you explain.
A study published in the July edition of Genome Biology says genetic matter, previously ignored by the scientific community, may play an important role in cancer.
The study by the St. Laurent Institute, a non-profit medical research institute focused on the systems biology of disease, a...
Cancer Research UK says more and more people are surviving malignant melanoma, the most dangerous form of skin cancer. Their latest statistics, published online this week, reveal that more than 8 in 10 people diagnosed with malignant melanoma will now survive the disease. Forty years ago...
The US FDA have notified the Austrian biotech company Activartis that Orphan Drug Designation (ODD) has been granted for its innovative Cancer Immunotherapy AV0113. The ODD applies specifically to the use of AV0113 for the treatment of malignant glioma, a very aggressive type of brain cancer...
A new genetic test for one of the most common forms of breast cancer will help doctors better identify those women who should be considered for chemotherapy, and those who can avoid it, say researchers. A team at The Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust...
Scientists at the University of East Anglia have made a major advancement in understanding tissue development that has important implications for cancer. Findings published today in the journal Cell Science show how the protein EB2 is a key regulator of tube-like structures inside cells and...
Consuming fish oils can significantly lower a person's risk of developing breast cancer, according to a new study published in the BMJ. The researchers reviewed 21 different independent prospective cohort studies, they found that a high intake of fish and marine n-3 polyunsaturated fatty acids...
In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed AAV-LPL S447X for the treatment of a rare inherited metabolic disease...
Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments for ovarian and breast cancers driven by a mutation in BRCA, a gene that made headlines...
New research from Germany suggests that persistent infection by Chlamydia may pave the way for cancer: not only does the pathogen cause mutations in host cell DNA, it also inhibits the cellular mechanisms that attempt to repair the damage. The researchers, from the Max Planck Institute for...
South Asian women in Britain have an 8% higher risk of developing breast cancer than British white women, compared to a 45% lower risk ten years ago, researchers from the University of Sheffield reported at the National Cancer Intelligence Network Conference in Brighton on Friday, June 14th...
UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques. In real time and in three dimensions, these technologies can show us how cancers spread and how active...
Here’s a good reason to pay attention in math class. Nature Communications has published a paper from Ottawa researchers today, outlining how advanced mathematical modelling can be used in the fight against cancer.
The technique predicts how different treatments and genetic modifications might...